4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001415889-25-000805
Options or other derivatives
- Chief Financial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Maestas Nicholas Chief Financial Officer | 2025-01-02 | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | D | ||
Loading xslF345X05/form4-01062025_050112.xml…